Hypomanic Episode
Hypomania is an abnormally revved-up state of mind that affects your mood, thoughts, and behavior, and is a potential symptom of bipolar disorder, particularly type II.
Cluster Number:
Wiki Number: W101
Diagnosis: Hypomanic Episode
US Patients:
World Patients:
Sex Ratio:
Age Onset: Age 18
Brain Area: lesions on the right side frontal and temporal lobes are associated with mania
Symptoms: need and get less sleep, have more energy, more talkative, flights of creative ideas; more competitive, but function fully
Progression: may have depression in fall and winter; hypomania in spring and summer – cyclical.
Causes: part of bipolar and schizophrenia; Bipolar II does not reach the same intensity of mania as Bipolar I, but become depressed
Medications: hypomania can usually be reduced by reducing the amount(s) of medication(s); antidepressants for 2-5 years
Therapies: CBT may help.
Youtube Video:
How it feels to have hypomania.
Youtube Video: Medical Shots: Mania vs. Hypomania
I did not find any medically-based books on Hypomanic Episode.
Support Group: nami.org; 800-950-6264
(National Alliance on Mental Illness)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosisÂ
Clicking each title opens the
PubMed article’s summary-abstract.
- Difference between Quantitative Electroencephalography, Loudness Dependence of Auditory Evoked Potential, and Mismatch Negativity between a Manic and a Depressive Episode in a Single Bipolar Patient with Mixed Featuresby Young-Min Park on April 16, 2024
This study compares the changes in Quantitative electroencephalography (QEEG), loudness dependence of auditory evoked potentials (LDAEP), and mismatch negativity (MMN) in the case of bipolar depression, mania, and euthymia in a single patient. the characteristic of QEEG in this patient with mixed depression was an increase in alpha; in mixed mania, there was little increase in alpha, and the decrease in delta, theta, and beta was noticeable. LDAEP increased more in the manic phase than in the...
- Effect of antipsychotics and mood stabilisers on metabolism in bipolar disorder: a network meta-analysis of randomised-controlled trialsby Lingzhuo Kong on April 15, 2024
BACKGROUND: Antipsychotics and mood stabilisers are gathering attention for the disturbance of metabolism. This network meta-analysis aims to evaluate and rank the metabolic effects of the commonly used antipsychotics and mood stabilisers in treating bipolar disorder (BD).
- Acute Onset of Mania and Psychosis in the Context of Long-COVID: A Case Studyby Orme W on April 15, 2024
Acute phase COVID-19 has been associated with an increased risk for several mental health conditions, but less is known about the interaction of long COVID and mental illness. Prior reports have linked long COVID to PTSD, depression, anxiety, obsessive compulsive symptoms, and insomnia. This case report describes a novel presentation of mania arising in the context of long COVID symptoms with attention given to possible interacting etiological pathways. The case report also highlights the need...
- Study on the Correlation between Hcy and Hs-CRP Levels and Cognitive Function in Patients with Bipolar Disorder and Borderline Personality Disorderby Chaomin Wang on April 15, 2024
CONCLUSION: High serum Hcy and hs-CRP expression levels may regulate inflammatory responses, aggravating cognitive impairment in patients with BD and BPD. Serum Hcy and hs-CRP expression levels are significantly related to cognitive dysfunction. They are expected to guide the prevention and treatment of BD comorbid BPD patients.